285 related articles for article (PubMed ID: 35328609)
1. Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.
Blasiak J; Chojnacki J; Pawlowska E; Jablkowska A; Chojnacki C
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328609
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of vitamin D receptor-associated lncRNAs in epileptic patients.
Mazdeh M; Zamani M; Eftekharian MM; Komaki A; Arsang-Jang S; Taheri M; Ghafouri-Fard S
Metab Brain Dis; 2019 Oct; 34(5):1457-1465. PubMed ID: 31187385
[TBL] [Abstract][Full Text] [Related]
4. Abnormal pattern of vitamin D receptor-associated genes and lncRNAs in patients with bipolar disorder.
Eghtedarian R; Ghafouri-Fard S; Bouraghi H; Hussen BM; Arsang-Jang S; Taheri M
BMC Psychiatry; 2022 Mar; 22(1):178. PubMed ID: 35279108
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients.
Taheri M; Rad LM; Hussen BM; Nicknafs F; Sayad A; Ghafouri-Fard S
BMC Infect Dis; 2021 Jun; 21(1):588. PubMed ID: 34147082
[TBL] [Abstract][Full Text] [Related]
6. A Combined Bioinformatics and Literature Based Approach for Identification of Long Non-coding RNAs That Modulate Vitamin D Receptor Signaling in Breast Cancer.
Kholghi Oskooei V; Ghafouri-Fard S; Omrani Mir D
Klin Onkol; 2018; 31(4):264-269. PubMed ID: 30541308
[TBL] [Abstract][Full Text] [Related]
7. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
8. The role of vitamin D in breast cancer risk and progression.
Vanhevel J; Verlinden L; Doms S; Wildiers H; Verstuyf A
Endocr Relat Cancer; 2022 Jan; 29(2):R33-R55. PubMed ID: 34935629
[TBL] [Abstract][Full Text] [Related]
9. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
10. Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.
Davoodi F; Brenner RV; Evans SR; Schumaker LM; Shabahang M; Nauta RJ; Buras RR
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):147-53. PubMed ID: 7662588
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
12. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
Chang PL; Lee TF; Garretson K; Prince CW
Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
[TBL] [Abstract][Full Text] [Related]
14. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
15. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
Kemmis CM; Welsh J
J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073
[TBL] [Abstract][Full Text] [Related]
16. Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer.
Kholghi Oskooei V; Geranpayeh L; Omrani MD; Ghafouri-Fard S
Cancer Manag Res; 2018; 10():3451-3462. PubMed ID: 30254488
[TBL] [Abstract][Full Text] [Related]
17. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
18. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
20. Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions.
Nishikawa M; Yasuda K; Takamatsu M; Abe K; Okamoto K; Horibe K; Mano H; Nakagawa K; Tsugawa N; Hirota Y; Horie T; Hinoi E; Okano T; Ikushiro S; Sakaki T
Sci Rep; 2020 Mar; 10(1):5677. PubMed ID: 32231239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
